BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 14720027)

  • 1. Targeting cysteinyl leukotrienes in patients with rhinitis, sinusitis and paranasal polyps.
    Parnes SM
    Am J Respir Med; 2002; 1(6):403-8. PubMed ID: 14720027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of leukotriene inhibitors in allergic rhinitis and paranasal sinusitis.
    Parnes SM
    Expert Opin Pharmacother; 2002 Jan; 3(1):33-8. PubMed ID: 11772331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of leukotriene inhibitors in allergic rhinitis and paranasal sinusitis.
    Parnes SM
    Curr Allergy Asthma Rep; 2002 May; 2(3):239-44. PubMed ID: 11918866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of leukotriene and its receptors in eosinophilic chronic rhinosinusitis with nasal polyps.
    Wu X; Hong H; Zuo K; Han M; Li J; Wen W; Xu G; Miao B; Li H
    Int Forum Allergy Rhinol; 2016 Jan; 6(1):75-81. PubMed ID: 26332237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antileukotrienes in upper airway inflammatory diseases.
    Cingi C; Muluk NB; Ipci K; Şahin E
    Curr Allergy Asthma Rep; 2015 Nov; 15(11):64. PubMed ID: 26385352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of leukotriene inhibitors in patients with paranasal sinus disease.
    Parnes SM
    Curr Opin Otolaryngol Head Neck Surg; 2003 Jun; 11(3):184-91. PubMed ID: 12923360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of leukotrienes and the effect of leukotriene receptor antagonists in allergic rhinitis].
    Kupryś I; Kuna P
    Pol Merkur Lekarski; 2000 Oct; 9(52):717-20. PubMed ID: 11144066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Ca2+ release-activated Ca2+ channel channels and leukotriene receptors provides a novel combination strategy for treating nasal polyposis.
    Di Capite J; Nelson C; Bates G; Parekh AB
    J Allergy Clin Immunol; 2009 Nov; 124(5):1014-21.e1-3. PubMed ID: 19895990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of leukotrienes in nasal allergy.
    Haberal I; Corey JP
    Otolaryngol Head Neck Surg; 2003 Sep; 129(3):274-9. PubMed ID: 12958580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Montelukast: new therapeutic option in patients with nasal polyps associated to respiratory allergic disease].
    Almeida Arvizu V; Guidos Fogelbach G; Sánchez Sánchez B; Vásquez Nava F; Matta Campos J; López Medina L; Rivera Pérez J; Mejía Covarrubias F; Montero Mora P
    Rev Alerg Mex; 2005; 52(4):151-8. PubMed ID: 16268183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cysteinyl leukotrienes induce nasal symptoms of allergic rhinitis via a receptor-mediated mechanism in guinea pigs.
    Fujita M; Nakagawa N; Yonetomi Y; Takeda H; Kawabata K; Ohno H
    Jpn J Pharmacol; 1997 Dec; 75(4):355-62. PubMed ID: 9469641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukotriene generation and clinical implications.
    Arm JP
    Allergy Asthma Proc; 2004; 25(1):37-42. PubMed ID: 15055561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Zafirlukast in treatment of nasal polyps in patients with aspirin intolerant bronchial asthma--preliminary report].
    Modrzyński M; Zawisza E; Rapiejko P
    Pol Merkur Lekarski; 2002 Mar; 12(69):224-7. PubMed ID: 12053594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on the experimental allergic rhinitis induced by Japanese cedar pollen--role of cysteinyl leukotrienes in nasal allergic symptoms].
    Mizutani N
    Yakugaku Zasshi; 2003 Jan; 123(1):1-8. PubMed ID: 12607939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of cysteinyl leukotrienes and their receptors in refractory nasal polyps.
    Du J; Ba L; Zhou J; Yu L; Liu R; Zhang J; Liu F; Xian J; Liu S; Liu Y
    Prostaglandins Leukot Essent Fatty Acids; 2017 Nov; 126():39-48. PubMed ID: 29031394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Leukotrien antagonists in the treatment of allergic rhinitis and comorbidities].
    Sacre Hazouri JA
    Rev Alerg Mex; 2008; 55(4):164-75. PubMed ID: 19058495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory properties of montelukast, a leukotriene receptor antagonist in patients with asthma and nasal polyposis.
    Schäper C; Noga O; Koch B; Ewert R; Felix SB; Gläser S; Kunkel G; Gustavus B
    J Investig Allergol Clin Immunol; 2011; 21(1):51-8. PubMed ID: 21370724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandins, leukotrienes and perennial rhinitis.
    Shahab R; Phillips DE; Jones AS
    J Laryngol Otol; 2004 Jul; 118(7):500-7. PubMed ID: 15318955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of montelukast in the treatment of asthma and allergic rhinitis.
    Nayak A
    Expert Opin Pharmacother; 2004 Mar; 5(3):679-86. PubMed ID: 15013935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role for cysteinyl leukotriene receptor antagonist therapy in asthma and their potential role in allergic rhinitis based on the concept of "one linked airway disease".
    Meltzer EO
    Ann Allergy Asthma Immunol; 2000 Feb; 84(2):176-85; quiz 185-7. PubMed ID: 10719774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.